Recent Posts
- Navigating seasonal changes can be difficult with chronic illness
- Biocryst sells European rights to HAE therapy Orladeyo for $250M
- Acquired angiodema may be first sign of underlying lymphoma
- Even years in, there are some HAE skills we have yet to master
- Ekterly approved as on-demand therapy for HAE in EU, Switzerland